In populations with known or suspected high levels of isoniazid resistance, new
TB patients may receive HRE as therapy in the continuation phase as an acceptable alternative to HR.
We use cookies on our website to give you the most relevant experience by remembering your preferences
during repeat visits. By clicking “Accept”, you consent to the use of all the cookies.
TB KaSPar
Feedback